BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11128035)

  • 21. Renal targeting of a non-steroidal anti-inflammatory drug: effects on renal prostaglandin synthesis in the rat.
    Haas M; Moolenaar F; Meijer DK; de Jong PE; de Zeeuw D
    Clin Sci (Lond); 1998 Nov; 95(5):603-9. PubMed ID: 9791047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Arginine vasopressin increases renal sodium excretion in the anesthetized rat through V1 receptors.
    Musabayane CT; Forsling ML; Balment RJ
    Ren Fail; 1997 Jan; 19(1):23-32. PubMed ID: 9044449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Furosemide interaction with the prostaglandin and kallikrein-kinin systems of the kidneys].
    Kuz'min OB; Mikhaĭlenko PV; Kriukova RA
    Farmakol Toksikol; 1986; 49(2):21-4. PubMed ID: 2423364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased urinary kallikrein with hyperglycemia in patients with short-term insulin-dependent diabetes mellitus.
    Pelikánová T; Pinsker P; Smrcková I; Stribrná L; Dryáková M
    J Diabetes Complications; 1998; 12(5):264-72. PubMed ID: 9747643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early increases in renal kallikrein secretion on administration of potassium or ATP-sensitive potassium channel blockers in rats.
    Fujita T; Hayashi I; Kumagai Y; Inamura N; Majima M
    Br J Pharmacol; 1999 Nov; 128(6):1275-83. PubMed ID: 10578142
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal effects of aprotinin, a kallikrein inhibitor in rats in saline diuresis.
    Kauker ML
    Proc Soc Exp Biol Med; 1985 Feb; 178(2):222-6. PubMed ID: 2578672
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute and chronic diuretic-induced alterations in urinary sodium and calcium excretion in the conscious rat.
    Hanson RC; White JB; Gomoll AW
    Miner Electrolyte Metab; 1982 Dec; 8(6):314-24. PubMed ID: 7167137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of water, sodium overloading and diuretics upon urinary kallikrein.
    Croxatto HR; Huidobro F; Rojas M; Roblero J; Albertini R
    Adv Exp Med Biol; 1976; 70(00):361-73. PubMed ID: 937140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Participation of the prostaglandin system in furosemide-induced changes of renal function in anesthetized rats.
    Yoshida M; Suzuki-Kusaba M; Satoh S
    Ren Physiol; 1987; 10(1):25-32. PubMed ID: 2446364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urinary thiamine excretion in the rat: effects of furosemide, other diuretics, and volume load.
    Lubetsky A; Winaver J; Seligmann H; Olchovsky D; Almog S; Halkin H; Ezra D
    J Lab Clin Med; 1999 Sep; 134(3):232-7. PubMed ID: 10482307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dynamics of renal excretory function after furosemide or ethacrynic acid administration to unanaesthetized dogs after mannitol infusion or chronic renal denervation.
    Girchev R; Kabakchieva E; Vrabchev N; Natcheff N; Natochin Y
    Acta Physiol Hung; 1985; 65(2):137-48. PubMed ID: 3920869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sulindac and ibuprofen inhibit furosemide-stimulated renin release but not natriuresis in men on a normal sodium diet.
    Riley LJ; Vlasses PH; Rotmensch HH; Swanson BN; Chremos AN; Johnson CL; Ferguson RK
    Nephron; 1985; 41(3):283-8. PubMed ID: 3903529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low-salt diet downregulates plasma but not tissue kallikrein-kinin system.
    Hilgenfeldt U; Puschner T; Riester U; Finsterle J; Hilgenfeldt J; Ritz E
    Am J Physiol; 1998 Jul; 275(1):F88-93. PubMed ID: 9689009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of insulin-induced changes in the renal response to furosemide in normal subjects.
    Sechi LA; Marigliano A; Tedde R
    Miner Electrolyte Metab; 1991; 17(6):383-9. PubMed ID: 1823389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics and pharmacodynamics of furosemide after direct administration into the stomach or duodenum.
    Lee WI; Yoon WH; Shin WG; Song IS; Lee MG
    Biopharm Drug Dispos; 1997 Dec; 18(9):753-67. PubMed ID: 9429740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of indomethacin on furosemide-stimulated urinary PGE2 excretion in man.
    Brater DC; Beck JM; Adams BV; Campbell WB
    Eur J Pharmacol; 1980 Jul; 65(2-3):213-9. PubMed ID: 7398787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of frusemide on the renal kallikrein-kinin system of the rat.
    Bönner G; Beck D; Deeg M; Marin-Grez M; Gross F
    Clin Sci (Lond); 1982 Nov; 63(5):447-53. PubMed ID: 6922014
    [No Abstract]   [Full Text] [Related]  

  • 38. Bumetanide and frusemide: a comparison of dose-response curves in healthy men.
    Ramsay LE; McInnes GT; Hettiarachchi J; Shelton J; Scott P
    Br J Clin Pharmacol; 1978 Mar; 5(3):243-7. PubMed ID: 656269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Natriuretic effect of [7-glycine]oxytocin in the presence of diuretic agents in conscious rats.
    Stier CT; Manning M; Sawyer WH
    J Pharmacol Exp Ther; 1980 Mar; 212(3):412-7. PubMed ID: 7359343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The acute effects of intravenous frusemide on the renal kallikrein kinin system in man: relationship to dose.
    Bicknell C; Campbell S; Waller D; Albano J
    Immunopharmacology; 1996 May; 32(1-3):122-4. PubMed ID: 8796287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.